SeqLL Inc. (SQL) 是一家上市公司 属于 医疗保健 板块，经营于 Medical - Diagnostics & Research 行业. 公司总部位于 Billerica, MA, 美国. 现任CEO为 Daniel Robert Jones.
SQL 拥有 IPO日期为 2021-08-27, 7 名全职员工, 在 NASDAQ Capital Marke, 市值为 $2.51M.
SeqLL Inc. operates as a life sciences instrumentation and research services company worldwide. The company designs, develops, and manufactures genetic analysis technologies. It offers true single molecule sequencing (tSMS) platform, which offers a single molecule solution for DNA and RNA sequencing. The company has a collaboration agreement with Bernstein Laboratory, Ting Laboratory, The Jackson Laboratory for Genomic Medicine, Weizmann Institute of Science, True Bearing Diagnostics, Inc., and Tetracore, Inc. It serves academic and government institutions, hospitals and medical centers, pharmaceutical and biotechnology companies, and non-profit research organizations. The company was founded in 2013 and is based in Billerica, Massachusetts.
